Halozyme Therapeutics, Inc. $(HALO)$ is currently at $46.88, down $7.08 or 13.12%
--Would be lowest close since June 5, 2024, when it closed at $45.65
--On pace for largest percent decrease since Jan. 13, 2016, when it fell 17.68%
--Currently down four consecutive days; down 23.26% over this period
--Longest losing streak since Oct. 25, 2024, when it fell for five straight trading days
--Worst four day stretch since the four days ending Jan. 19, 2016, when it fell 25.2%
--Down 7.3% month-to-date
--Up 26.84% year-to-date; on pace for best year since 2022, when it rose 41.51%
--Down 27.23% from its all-time closing high of $64.42 on Aug. 28, 2024
--Up 17.41% from 52 weeks ago (Nov. 17, 2023), when it closed at $39.93
--Down 27.23% from its 52-week closing high of $64.42 on Aug. 28, 2024
--Up 39.19% from its 52-week closing low of $33.68 on Feb. 5, 2024
--Traded as low as $45.71; lowest intraday level since June 5, 2024, when it hit $44.38
--Down 15.29% at today's intraday low; largest intraday percent decrease since March 18, 2020, when it fell as much as 15.38%
All data as of 11:42:21 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 15, 2024 11:46 ET (16:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.